HELPER T-CELLS INFILTRATING HUMAN RENAL-CELL CARCINOMAS HAVE THE PHENOTYPE OF ACTIVATED MEMORY-LIKE T-LYMPHOCYTES

被引:18
作者
ALEXANDER, RB
FITZGERALD, EB
MIXON, A
CARTER, CS
JAKOBSEN, M
COHEN, PA
ROSENBERG, SA
机构
[1] NCI, SURG BRANCH, BETHESDA, MD 20892 USA
[2] NIH, CTR CLIN, DEPT TRANSFUS MED, BETHESDA, MD 20892 USA
关键词
RENAL CARCINOMA CELLS; CD4(+) T CELLS; SURFACE MARKERS; PHENOTYPE; T-LYMPHOCYTES;
D O I
10.1097/00002371-199501000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human renal cell carcinomas are characterized by an inflammatory infiltrate containing many T lymphocytes. Attempts to grow T cells from such tumors by culture in interleukin (IL)-2 have yielded heterogeneous populations of cells with functional characteristics typical of lymphokine-activated killer cells obtained by similar culture of cells from peripheral blood mononuclear cells. We examined a panel of surface markers expressed on T lymphocytes to determine if the CD4(+) T cells infiltrating human renal cell carcinomas are different from those in peripheral blood mononuclear cells. By flow cytometry analysis the CD4(+) T cells in a panel of freshly digested human renal cell carcinoma primary and metastatic tumors expressed the activation markers CD69 and HLA-DR and manifested an increase in CD45RO and a reciprocal decrease in CD45RA expression as compared with peripheral blood CD4(+) T cells. This suggests that CD4(+) T cells infiltrating renal cell carcinomas are activated and have encountered antigen. However, the expression of the IL-2R a chain (CD25) was not different in tumor-infiltrating CD4(+) T cells and peripheral blood CD4(+) T cells, suggesting that T cells infiltrating human renal cell carcinomas may have a block in proliferative capacity. The general failure of cultured tumor-infiltrating lymphocyte (TIL) from renal cell carcinoma to demonstrate tumor-specific reactivity may be due to the failure of such cells to grow in IL-2.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 30 条
  • [1] ALEXANDER JP, 1993, CANCER RES, V53, P1380
  • [2] BALCH CM, 1990, ARCH SURG-CHICAGO, V125, P200
  • [3] BELL EB, 1991, SEMIN IMMUNOL, V4, P43
  • [4] BELLDEGRUN A, 1993, J UROLOGY, V150, P1384, DOI 10.1016/S0022-5347(17)35785-3
  • [5] BUKOWSKI RM, 1991, CANCER RES, V51, P4199
  • [6] CARDI G, 1989, CANCER RES, V49, P6562
  • [7] USE OF A CONTINUOUS-FLOW CELL SEPARATOR IN DENSITY GRADIENT ISOLATION OF LYMPHOCYTES
    CARTER, CS
    LEITMAN, SF
    CULLIS, H
    MUUL, LM
    NASONBURCHENAL, K
    ROSENBERG, SA
    KLEIN, HG
    [J]. TRANSFUSION, 1987, 27 (04) : 362 - 365
  • [8] CLEMENT LT, 1988, J IMMUNOL, V141, P1464
  • [9] FINKE J, 1991, IMMUNOTHERAPY RENAL, P119
  • [10] FINKE JH, 1990, CANCER RES, V50, P2363